This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Orion.New evidence demonstrates early use of Stalevo(Rm) improves quality of life and may provide long-term benefits in patients with Parkinson's disease. Media Release: 31 Oct 2006. Available from: URL: http://www.orion.fi
Rights and permissions
About this article
Cite this article
New QOL evidence for levodopa/carbidopa/entacapone in PD. Pharmacoecon. Outcomes News 517, 9 (2006). https://doi.org/10.2165/00151234-200605170-00024
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605170-00024